author-photo

Paula R. Pohlmann

MedStar Georgetown University Hospital

18

Papers

83

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (1)
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer

2020 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (2)
An evaluation of palbociclib as a breast cancer treatment option: a current update.

2020 Expert Opinion on Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (1)
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (7)
Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-09-04: Prevalence of phosphatidylinositol-3-kinase (PI3K) pathway alterations and co-alteration of other markers in breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT2-03-04: A trial of induction Talazoparib followed by a combination of Talazoparib and Avelumab in advanced breast cancer: The TALAVE study

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract OT3-04-01: Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: The OXEL study

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract CT028: Atezolizumab (atezo) + nab-paclitaxel (nab-pac) in metastatic triple-negative breast cancer (mTNBC): 2-year update from a ph Ib trial

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials

2018 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (6)